{
    "title": "Novo Nordisk stops Ozempic kidney trial after early signs of success",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12616879/Novo-Nordisk-stops-Ozempic-kidney-trial-early-signs-success.html",
    "date": "2023-10-10",
    "keywords": [
        "trial",
        "drug",
        "wingrove",
        "year",
        "study",
        "drugmaker",
        "ingredient",
        "kidney",
        "company",
        "nordisk",
        "tuesday",
        "ozempic",
        "failure",
        "schedule",
        "analysis",
        "treatment",
        "recommendation",
        "board",
        "evidence",
        "trading",
        "semaglutide",
        "progression",
        "disease",
        "risk",
        "death",
        "heart",
        "wegovy",
        "analyst",
        "field",
        "note",
        "companys",
        "decision",
        "view",
        "glp1",
        "receptor",
        "purpose",
        "start",
        "novo",
        "wave",
        "demand",
        "weightloss",
        "briefly",
        "luxury",
        "brand",
        "lvmh",
        "september",
        "rise",
        "august",
        "success",
        "boom",
        "denmark",
        "foundation",
        "reporting",
        "york",
        "roy",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}